SCHEMBL13977941

SCHEMBL13977941

C=N/C(=N\N=C(\C)N)c1ccccn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.44
▸ LMNA P02545 2/20 0.39
▸ CES2 O00748 1/20 0.39
▸ CES1 P23141 1/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ ADRA2A P08913 1/20 0.39
▸ ADRA2B P18089 1/20 0.39
▸ ADRA2C P18825 1/20 0.39
▸ RAB9A P51151 7/20 0.38
▸ SMN1; SMN2 Q16637 4/20 0.38
▸ MAPT P10636 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ ALOX12 P18054 1/20 0.38
▸ GFER P55789 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ NPC1 O15118 5/20 0.38
▸ NAPRT Q6XQN6 1/20 0.38
▸ P4HTM Q9NXG6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13978223 0.85 NPC1 (0.45) KDM4EALDH1A1LMNACES2CES1
SCHEMBL13977939 0.77 CES2 (0.39) KDM4EALDH1A1LMNACES2CES1
SCHEMBL18909543 0.74 KDM4E (0.46) KDM4EALDH1A1LMNACES2CES1
SCHEMBL19889808 0.73 KDM4E (0.44) KDM4EALDH1A1LMNACES2CES1
SCHEMBL18653617 0.69 NPC1 (0.54) KDM4EALDH1A1LMNACES2CES1
SCHEMBL1256130 0.69 KDM4E (0.73) KDM4EALDH1A1LMNACES2CES1
Hydrochloric Acid SCHEMBL4201173 0.69 ALDH1A1 (0.59) KDM4EALDH1A1LMNACES2CES1
SCHEMBL22606420 0.68 KDM4E (0.50) KDM4EALDH1A1LMNACES2CES1
SCHEMBL10157706 0.68 KDM4E (0.50) KDM4EALDH1A1LMNAKMT2ARAB9A
SCHEMBL19785756 0.67 CES2 (0.50) KDM4EALDH1A1LMNACES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023250157-A9 INHIBITORS OF MYCOBACTERIUM TUBERCULOSIS LIPOAMIDE DEHYDROGENASE CORNELL UNIVERSITY (US) 2024-01-25 — — WO disclosed
WO-2012156920-A1 BIO-ORTHOGONAL DRUG ACTIVATION KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) 2012-11-22 — — WO disclosed
Send feedback